The next generation: Urinary epidermal growth factor is associated with an early decline in kidney function in children and adolescents with type 1 diabetes mellitus.


Journal

Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 23 05 2021
revised: 28 06 2021
accepted: 04 07 2021
pubmed: 11 7 2021
medline: 25 11 2021
entrez: 10 7 2021
Statut: ppublish

Résumé

Micro-albuminuria is considered an early clinical sign of diabetes nephropathy, however, early decrease of glomerular filtration can be present years before the presence of microalbuminuria. In this study, we explored whether urinary epidermal growth factor (uEGF) might serve as an early marker of diabetes nephropathy compared to microalbuminuria in children and adolescents. Children with type 1 diabetes mellitus (n = 158) and healthy controls (n = 40) were included in this study. Serum and urine samples were collected three times with an interval of at least one month to determine creatinine (serum and urine), epidermal growth factor and albumin (urine). Demographic data and routine lab values were extracted out of the electronic patient files. uEGF was significantly lower in children with T1DM compared to healthy controls (p = 0.032). A relatively lower glomerular filtration rate (eGFR) was associated with a decreased uEGF (p < 0.001). uEGF was independently associated with eGFR in a multivariate analysis. This study provides evidence that uEGF can serve as an early marker of diabetes nephropathy in children and adolescents.

Identifiants

pubmed: 34245799
pii: S0168-8227(21)00305-3
doi: 10.1016/j.diabres.2021.108945
pii:
doi:

Substances chimiques

Biomarkers 0
Epidermal Growth Factor 62229-50-9
Creatinine AYI8EX34EU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108945

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Auteurs

Kristien J Ledeganck (KJ)

Laboratory of Experimental Medicine and Paedciatrics and member of the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium. Electronic address: kristien.ledeganck@uantwerpen.be.

Marieke den Brinker (M)

Laboratory of Experimental Medicine and Paedciatrics and member of the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium; Department of Paediatric Endocrinology, Antwerp University Hospital, Antwerp, Belgium.

Emma Peeters (E)

Laboratory of Experimental Medicine and Paedciatrics and member of the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.

Aline Verschueren (A)

Laboratory of Experimental Medicine and Paedciatrics and member of the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.

Benedicte Y De Winter (BY)

Laboratory of Experimental Medicine and Paedciatrics and member of the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.

Annick France (A)

Department of Paediatric Endocrinology, Antwerp University Hospital, Antwerp, Belgium.

Hilde Dotremont (H)

Department of Paediatric Endocrinology, Antwerp University Hospital, Antwerp, Belgium.

Dominique Trouet (D)

Laboratory of Experimental Medicine and Paedciatrics and member of the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium; Department of Paediatric Nephrology, Antwerp University Hospital, Antwerp, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH